STK11 and thyroid cancer: Taken together, the results of the present study revealed, for the first time, that LKB1 could inhibit proliferation, metastasis phenotype and angiogenesis, and reverse EMT in thyroid cancer in vitro and vivo via the upregulation of SIK1.